|
C3ORF33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.95319999957344E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96280000031024E-07 |
| Normal-vs-Stage2 |
1.292960E-01 |
| Normal-vs-Stage3 |
2.422100E-02 |
| Normal-vs-Stage4 |
1.92736999999887E-05 |
| Stage1-vs-Stage2 |
2.199400E-01 |
| Stage1-vs-Stage3 |
3.841400E-01 |
| Stage1-vs-Stage4 |
3.514600E-01 |
| Stage2-vs-Stage3 |
7.338800E-01 |
| Stage2-vs-Stage4 |
1.439850E-01 |
| Stage3-vs-Stage4 |
2.079200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.95929999966683E-07 |
| Normal-vs-AfricanAmerican |
1.625500E-04 |
| Normal-vs-Asian |
4.780400E-01 |
| Caucasian-vs-AfricanAmerican |
7.295800E-01 |
| Caucasian-vs-Asian |
6.193800E-01 |
| AfricanAmerican-vs-Asian |
7.580400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.49420000209E-08 |
| Normal-vs-Female |
2.166100E-02 |
| Male-vs-Female |
6.200300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.839300E-03 |
| Normal-vs-Extreme_Weight |
3.55089999959368E-07 |
| Normal-vs-Obese |
1.40169999995887E-06 |
| Normal-vs-Extreme_Obese |
3.463400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.335600E-01 |
| Normal_Weight-vs-Obese |
4.324000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.908200E-01 |
| Extreme_Weight-vs-Obese |
8.250000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.769390E-01 |
| Obese-vs-Extreme_Obese |
1.790960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.223160E-01 |
| Normal-vs-Age(41-60Yrs) |
7.93119999999981E-05 |
| Normal-vs-Age(61-80Yrs) |
1.09999999997612E-07 |
| Normal-vs-Age(81-100Yrs) |
1.130350E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.080200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.332600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.573800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.458640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.567000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.023600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.4018000000019E-05 |
| Normal-VS-Type2 PRCC |
1.51936999999158E-05 |
| Normal-VS-KIRP CIMP |
2.418600E-04 |
| Normal-VS-Unclassified PRCC |
2.032900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.323620E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.187800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.873020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.072200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.955000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.601000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.80790000000287E-05 |
| Normal-vs-N1 |
5.494400E-02 |
| Normal-vs-N2 |
1.280320E-03 |
| N0-vs-N1 |
4.835800E-01 |
| N0-vs-N2 |
4.770000E-01 |
| N1-vs-N2 |
3.783400E-01 |
|
|
